Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04894851 · ClinicalTrials.gov registry record · NA

Contingency Management for Hoarding Disorder

A NA study, sponsored by Hartford Hospital.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT04894851: Completed NA study, sponsored by Hartford Hospital.

NCT04894851 is a NA study that has completed, run by Hartford Hospital. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04894851, a NA study, has completed, sponsored by Hartford Hospital.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

Aim 1: To test the efficacy of contingency management for patients with hoarding disorder (HD). Hypothesis 1. Participants completing CM will show significant pre- to post-treatment decreases in severity of hoarding symptoms and clinician-rated impairment, and significant increases in quality of life. Exploratory analyses will examine whether effect sizes compare with those of prior trials of cognitive-behavioral therapy (CBT) for HD conducted within our clinic, whether problem severity at follow-up is predicted by hoarding severity measured immediately after treatment completion, and whether readiness for change improves with treatment.

Primary Outcome

A brief 5-item interview to rate clutter, difficulty discarding, acquisition, distress, and impairment. Each item is rated on a likert scale from 1 to 8, with higher scores reflective of higher symptom severity.

Interventions

  • BEHAVIORAL Contingency Management

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2013-08
Est. Completion 2014-10
Phase NA
Hartford Hospital

75 total trials

What the finished NCT04894851 record still lists

NCT04894851 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Contingency Management is the first listed.

NCT04894851 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04894851 about?

NCT04894851 is a clinical study titled "Contingency Management for Hoarding Disorder". Aim 1: To test the efficacy of contingency management for patients with hoarding disorder (HD). Hypothesis 1. Participants completing CM will show significant pre- to post-treatment decreases in severity of hoarding symptoms and clinician-rated impairment, and significant increases in quality of li...

What is the current status of trial NCT04894851?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2013-08. Estimated completion is 2014-10.

What interventions are being tested in trial NCT04894851?

The interventions under investigation include: Contingency Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT04894851?

This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04894851's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT04894851, the US trial registry maintained by the National Library of Medicine. NCT04894851 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.